Your browser doesn't support javascript.
loading
Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial.
Wu, Hongyi; Xu, Lili; Zhao, Xin; Zhang, Huanyi; Cheng, Kang; Wang, Xiaoyan; Chen, Manhua; Li, Guangping; Huang, Jiangnan; Lan, Jun; Wei, Guanghe; Zhang, Chi; Wang, Yinman; Qian, Juying; Ge, Junbo.
Afiliação
  • Wu H; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Xu L; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Zhao X; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Zhang H; Department of Cardiology, Taian City Central Hospital, Shandong, China (H.Y.Z.).
  • Cheng K; Department of Cardiology, Xi'an No. 3 Hospital, Affiliated Hospital of Northwest University, Xi'an, Shanxi, China (K.C.).
  • Wang X; Department of Cardiology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China (X.Y.W.).
  • Chen M; Department of Cardiology, Central Hospital of Wuhan, Hubei, China (M.H.C.).
  • Li G; Department of Cardiology, Second Hospital of Tianjin Medical University, China (G.P.L.).
  • Huang J; Department of Cardiology, First Affiliated Hospital of Guangxi Medical University, Nanning, China (J.N.H.).
  • Lan J; Department of Cardiology, Dongguan Third People's Hospital, Guangdong, China (J.L.).
  • Wei G; Department of Cardiology, Affiliated Hospital of Jining Medical University, Shandong, China (G.H.W.).
  • Zhang C; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Wang Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Qian J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
  • Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, China (H.Y.W., L.L.X., X.Z., C.Z., Y.M.W., J.Y.Q., J.B.G.).
Circulation ; 147(3): 212-222, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36335890
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Stents Farmacológicos / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Stents Farmacológicos / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos